company background image
PPP logo

Phong Phu Pharmaceutical HNX:PPP Stock Report

Last Price

₫18.10k

Market Cap

₫159.3b

7D

1.7%

1Y

28.4%

Updated

07 Apr, 2024

Data

Company Financials

Phong Phu Pharmaceutical Joint Stock Company

HNX:PPP Stock Report

Market Cap: ₫159.3b

PPP Stock Overview

Phong Phu Pharmaceutical Joint Stock Company se dedica a la producción, venta y distribución de medicamentos principalmente en Vietnam.

PPP fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends3/6

Phong Phu Pharmaceutical Joint Stock Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Phong Phu Pharmaceutical
Historical stock prices
Current Share Price₫18,100.00
52 Week High₫20,600.00
52 Week Low₫13,000.00
Beta-0.18
1 Month Change-3.72%
3 Month Change9.70%
1 Year Change28.37%
3 Year Change40.31%
5 Year Change116.41%
Change since IPO89.62%

Recent News & Updates

Recent updates

Shareholder Returns

PPPVN PharmaceuticalsVN Market
7D1.7%-0.5%-2.3%
1Y28.4%26.4%16.5%

Rentabilidad frente al sector: PPP superó al sector VN Pharmaceuticals , que obtuvo un rendimiento del 15% el año pasado.

Rentabilidad vs. Mercado: PPP superó al mercado VN, que obtuvo un rendimiento del 21.9% el año pasado.

Price Volatility

Is PPP's price volatile compared to industry and market?
PPP volatility
PPP Average Weekly Movement6.9%
Pharmaceuticals Industry Average Movement3.0%
Market Average Movement4.0%
10% most volatile stocks in VN Market6.8%
10% least volatile stocks in VN Market2.1%

Precio estable de las acciones: PPP no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: PPP(9%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de los valores de VN.

About the Company

FoundedEmployeesCEOWebsite
2000n/an/ahttps://duocphongphu.vn

Phong Phu Pharmaceutical Joint Stock Company se dedica a la producción, venta y distribución de medicamentos principalmente en Vietnam. Los medicamentos de la empresa se derivan de hierbas medicinales, productos químicos farmacéuticos y alimentos para la protección de la salud, que se ofrecen en comprimidos, recubiertos con película, recubiertos de azúcar, cápsulas blandas, gránulos, polvo y otras formas. Ofrece sus productos para problemas respiratorios, espirituales, antiinflamatorios, antialérgicos, digestivos, cardiovasculares, diabetes, función hepática y artrosis, además de proporcionar vitaminas y minerales.

Phong Phu Pharmaceutical Joint Stock Company Fundamentals Summary

How do Phong Phu Pharmaceutical's earnings and revenue compare to its market cap?
PPP fundamental statistics
Market cap₫159.28b
Earnings (TTM)₫20.12b
Revenue (TTM)₫152.17b

7.9x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PPP income statement (TTM)
Revenue₫152.17b
Cost of Revenue₫103.00b
Gross Profit₫49.17b
Other Expenses₫29.05b
Earnings₫20.12b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)2.29k
Gross Margin32.31%
Net Profit Margin13.22%
Debt/Equity Ratio0%

How did PPP perform over the long term?

See historical performance and comparison

Dividends

7.7%

Current Dividend Yield

66%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.